0001179110-18-013009.txt : 20181119
0001179110-18-013009.hdr.sgml : 20181119
20181119180926
ACCESSION NUMBER: 0001179110-18-013009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181119
FILED AS OF DATE: 20181119
DATE AS OF CHANGE: 20181119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRAVES FRED B
CENTRAL INDEX KEY: 0001014095
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 181193682
MAIL ADDRESS:
STREET 1: 750 BATTERY ST
STREET 2: STE 600
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BARR HARBOR DRIVE, SUITE 400
CITY: WEST CONSHOHOCKEN
STATE: PA
ZIP: 19428
BUSINESS PHONE: 404-380-9263
MAIL ADDRESS:
STREET 1: 200 BARR HARBOR DRIVE, SUITE 400
CITY: WEST CONSHOHOCKEN
STATE: PA
ZIP: 19428
FORMER COMPANY:
FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20010815
4
1
edgar.xml
FORM 4 -
X0306
4
2018-11-19
0
0001157601
MADRIGAL PHARMACEUTICALS, INC.
MDGL
0001014095
CRAVES FRED B
C/O BAY CITY CAPITAL, LLC
750 BATTERY STREET, SUITE 400
SAN FRANCISCO
CA
94111
1
0
1
0
Common Stock
2018-11-19
4
P
0
100
123.17
A
296167
D
Common Stock
2018-11-19
4
P
0
1000
124.57
A
297167
D
Common Stock
2018-11-19
4
P
0
900
125
A
298067
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.00 to $124.82, inclusive. Thereporting person undertakes to provide to Madrigal Pharmaceuticals, Inc., any security holder of Madrigal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
/s/ Fred B. Craves
2018-11-19